Meredith C. Henderson, Ph.D.
Affiliations: | 2008 | Cancer Biology | University of Arizona, Tucson, AZ |
Area:
Molecular Biology, OncologyGoogle:
"Meredith Henderson"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Robert T. Dorr | grad student | 2008 | University of Arizona | |
| (UA62784; a putative inhibitor of CENP-E kinesin-like protein and its effects on human pancreatic cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Henderson MC, Azorsa DO. (2012) The genomic and proteomic content of cancer cell-derived exosomes. Frontiers in Oncology. 2: 38 |
| Henderson MC, Gonzales IM, Arora S, et al. (2011) High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells. Molecular Cancer Research : McR. 9: 724-32 |
| Savas S, Azorsa DO, Jarjanazi H, et al. (2011) NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells. Plos One. 6: e18306 |
| Shaw AY, Henderson MC, Flynn G, et al. (2009) Characterization of novel diaryl oxazole-based compounds as potential agents to treat pancreatic cancer. The Journal of Pharmacology and Experimental Therapeutics. 331: 636-47 |
| Azorsa DO, Gonzales IM, Basu GD, et al. (2009) Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. Journal of Translational Medicine. 7: 43 |
| Henderson MC, Shaw YJ, Wang H, et al. (2009) UA62784, a novel inhibitor of centromere protein E kinesin-like protein. Molecular Cancer Therapeutics. 8: 36-44 |